CompletedNCT01548612
Sodium Nitroprusside Added to Usual Care for Schizophrenia
About this title
Read the official source —Medication studyAges 18–45Brazil
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.
- Listed locations
- Ribeirão PretoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateFebruary 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- University of Sao Paulo
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Brazil
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT01548612
- Official title
Show the full official title
Randomised Double Blind Placebo Controlled Study of Sodium Nitroprusside Added to Treatment as Usual in Patients With Schizophrenia
Get this study by email
Recruitment & locations
CompletedRibeirão Preto
Questions about this study
Who is behind this study?
The study sponsor is University of Sao Paulo, a university.
Did this study involve medication?
Yes. The study involved medication, including Sodium nitroprusside and Glucose solution.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.
